+
Site Tour

TAVI 2023: New indications and trends in TAVI – Asymptomatic aortic stenosis

In this opening session of the first annual TAVI Summit, Henryk Dreger presents on the main indications for aortic valve replacement in asymptomatic aortic stenosis.

Watch on Demand videos on TAVI Summit 2023

Related Videos

TAVI 2023: Younger patients

TAVI Summit 2023: Streamline implantation

TAVI 2023: Optimizing TAVI

TAVI Summit 2023: AS with HF

TAVI Summit - Cardiac imaging and morphology

TAVI Summit - Cardiac imaging and morphology

Now you've got Navitor

TAVI 2023: The next level

EACVI Summit 2023: Congress symposium

TAVI Summit - TAVR in bicuspid

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

Now you've got Navitor.
Future ready.

Tendyne™: Animation

TAVI Summit - Cardiac imaging and morphology

M-TEER: echo procedural approach

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ 30-day outcomes

Navitor Valve in small aortic annuli

ACC 2023: COAPT™ trial

bRIGHT study

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline